1. Tu JV, Willison DJ, Silver FL, Fang J, Richards JA, Laupacis A, et al. Impracticability of informed consent in the registry of the Canadian stroke network. N Engl J Med. 2004; 350:1414–1421.
Article
2. Lindley RI, Kane I, Cohen G, Sandercock PA. Factors influencing the use of different methods of consent in a randomized acute stroke trial: the third international stroke trial (IST-3). Int J Stroke. 2022; 17:553–558.
Article
3. Shalowitz DI, Garrett-Mayer E, Wendler D. The accuracy of surrogate decision makers: a systematic review. Arch Intern Med. 2006; 166:493–497.
4. Shamy M, Dewar B, Niznick N, Nicholls S, Dowlatshahi D. Advanced consent for acute stroke trials. Lancet Neurol. 2021; 20:170.
Article
5. Udoh U, Dewar B, Nicholls S, Fedyk M, Fahed R, Perry J, et al. Advance consent in acute stroke trials: survey of Canadian stroke physicians. Can J Neurol Sci. 2024; 51:122–125.
Article
6. Seeger R, Udoh U, Dewar B, Nicholls S, Fedyk M, Fahed R, et al. Advance consent in acute stroke trials: survey of Canadian research ethics board chairs. Can J Neurol Sci. 2024; 51:285–288.
Article
7. Udoh U, Seeger R, Cummings E, Dewar B, Nicholls S, Fedyk M, et al. Advance consent for participation in acute stroke trials: a focus group study with people with lived experience of stroke. Can J Neurol Sci. 2024 Oct 15 [Epub]. Available from:
https://doi.org/10.1017/cjn.2024.302.
Article
8. Canadian Institutes of Health Research, Natural Sciences and Engineering Research Council of Canada, Social Sciences and Humanities Research Council of Canada. Tri-council policy statement: ethical conduct for research involving humans – TCPS 2 [Internet]. Ottawa: Government of Canada;2022. [accessed February 9, 2023]. Available from:
https://ethics.gc.ca/eng/policy-politique_tcps2-eptc2_2022.html.